Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters
Open accessAbstract
Adeno-associated viral vectors are widely used as vehicles for gene transfer to the nervous system. The promoter and viral vector serotype are two key factors that determine the expression dynamics of the transgene. A previous comparative study has demonstrated that AAV1 displays efficient transduction of layer V corticospinal neurons, but the optimal promoter for transgene expression in corticospinal neurons has not been determined yet. In this paper, we report a side-by-side comparison between four commonly used promoters: the short CMV early enhancer/chicken β actin (sCAG), human cytomegalovirus (hCMV), mouse phosphoglycerate kinase (mPGK) and human synapsin (hSYN) promoter. Reporter constructs with each of these promoters were packaged in AAV1, and were injected in the sensorimotor cortex of rats and mice in order to transduce the corticospinal tract. Transgene expression levels and the cellular transduction profile were examined after 6 weeks. The AAV1 vectors harbouring the hCMV and sCAG promoters resulted in transgene expression in neurons, astrocytes and oligodendrocytes. The mPGK and hSYN promoters directed the strongest transgene expression. The mPGK promoter did drive expression in cortical neurons and oligodendrocytes, while transduction with AAV harbouring the hSYN promoter resulted in neuron-specific expression, including perineuronal net expressing interneurons and layer V corticospinal neurons. This promoter comparison study contributes to improve transgene delivery into the brain and spinal cord. The optimized transduction of the corticospinal tract will be beneficial for spinal cord injury research.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The ability of the recombinant AAV genome to persist as an episome in post-mitotic cells, such as neurons, ensures long-term expression even after a single administration.
“Especially considering the ability of the recombinant AAV genome to persist as an episome in post-mitotic cells, such as neurons, which ensures long-term expression even after a single administration [130-132].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [130]
The Conclusions report neuronal transgene expression in mice and rats six weeks after AAV injection, supporting expression after administration. They do not say that the recombinant AAV genome persists as an episome in post-mitotic cells or that this mechanism ensures long-term expression; those parts of the claim are unsupported by our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 87 · Cited by 114
Research works printed but not linked: 78
- [1]Hilton BJ Bradke F Can injured adult CNS axons regenerate by recapitulating development? Development 2017 144 3417 29 28974639
- [2]Mahar M Cavalli V Intrinsic mechanisms of neuronal axon regeneration Nat Rev Neurosci 2018 19 323 37 29666508 PMC5987780
- [3]Nieuwenhuis B Haenzi B Andrews MR Verhaagen J Fawcett JW Integrins promote axonal regeneration after injury of the nervous system Biol Rev 2018 93 1339 62 29446228 PMC6055631
- [4]Hutson TH Giovanni SD The translational landscape in spinal cord injury: focus on neuroplasticity and regeneration Nat Rev Neurol 2019 16 732 45 31728042
- [5]Gioanni Y Lamarche M A reappraisal of rat motor cortex organization by intracortical microstimulation Brain Res 1985 344 49 61 4041868
- [6]Neafsey EJ Bold EL Haas G Hurley-Gius KM Quirk G Sievert CF The organization of the rat motor cortex: a microstimulation mapping study Brain Res Rev 1986 11 77 96 3708387
- [7]Brecht M Krauss A Muhammad S Sinai-Esfahani L Bellanca S Margrie TW Organization of rat vibrissa motor cortex and adjacent areas according to cytoarchitectonics, microstimulation, and intracellular stimulation of identified cells J Comp Neurol 2004 479 360 73 15514982
- [8]Miller MW The origin of corticospinal projection neurons in rat Exp Brain Res 1987 67 339 51 3622693
- [9]Casale EJ Light AR Rustioni A Direct projection of the corticospinal tract to the superficial laminae of the spinal cord in the rat J Comp Neurol 1988 278 275 86 3230165
- [10]Liang P Moret V Wiesendanger M Rouiller EM Corticomotoneuronal connections in the rat: evidence from double-labeling of motoneurons and corticospinal axon arborizations J Comp Neurol 1991 311 356 66 1720143
- [11]Brösamle C Schwab ME Cells of origin, course, and termination patterns of the ventral, uncrossed component of the mature rat corticospinal tract J Comp Neurol 1997 386 293 303 9295153
- [12]Steward O Zheng B Ho C Anderson K Tessier-Lavigne M The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions J Comp Neurol 2004 472 463 77 15065120
- [13]Bareyre FM Kerschensteiner M Misgeld T Sanes JR Transgenic labeling of the corticospinal tract for monitoring axonal responses to spinal cord injury Nat Med 2005 11 1355 60 16286922
- [14]Gray SJ Gene therapy and neurodevelopmental disorders Neuropharmacology 2013 68 136 42 22750077
- [15]Ojala DS Amara DP Schaffer DV Adeno-associated virus vectors and neurological gene therapy Neuroscientist 2015 21 84 98 24557878
- [16]Naso MF Tomkowicz B Perry WL Strohl WR Adeno-associated virus (AAV) as a vector for gene therapy BioDrugs 2017 31 317 34 28669112 PMC5548848
- [17]Schultz BR Chamberlain JS Recombinant adeno-associated virus transduction and integration Mol Ther 2008 16 1189 99 18500252 PMC2574934
- [18]Huang L-Y Halder S Agbandje-McKenna M Parvovirus glycan interactions Curr Opin Virol 2014 7 108 18 25047752 PMC4149944
- [20]Hutson TH Verhaagen J Yáñez-Muñoz RJ Moon LDF Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector Gene Ther 2012 19 49 60 21562590 PMC3160493
- [21]Watakabe A Ohtsuka M Kinoshita M Takaji M Isa K Mizukami H Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex Neurosci Res 2015 93 144 57 25240284
- [22]Hadaczek P Stanek L Ciesielska A Sudhakar V Samaranch L Pivirotto P Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington’s disease Mol Ther Methods Clin Dev 2016 3 16037 27408903 PMC4926858
- [23]Hammond SL Leek AN Richman EH Tjalkens RB Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection PLoS ONE 2017 12 e0188830 29244806 PMC5731760
- [24]Fagoe ND Eggers R Verhaagen J Mason MRJ A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons Gene Ther 2014 21 242 52 24285216
- [25]Korecka J, Schouten M, Eggers R, Ulusoy A, Bossers K, Verhaagen J. Comparison of AAV serotypes for gene delivery to dopaminergic neurons in the substantia nigra. Viral Gene Ther. 2011. 10.5772/18939. · DOI
- [26]Schmitz SK Hjorth JJJ Joemai RMS Wijntjes R Eijgenraam S de Bruijn P Automated analysis of neuronal morphology, synapse number and synaptic recruitment J Neurosci Methods 2011 195 185 93 21167201
- [27]Verhaagen J Hobo B Ehlert EME Eggers R Korecka JA Hoyng SA Boon CJF Wijnholds J Small scale production of recombinant adeno-associated viral vectors for gene delivery to the nervous system Retinal gene therapy 2018 New York, NY Springer New York 3 17 29188502
- [29]Koseki H Donegá M Lam BY Petrova V van Erp S Yeo GS Selective rab11 transport and the intrinsic regenerative ability of CNS axons eLife 2017 6 e26956 28829741 PMC5779230
- [30]Eva R Koseki H Kanamarlapudi V Fawcett JW EFA6 regulates selective polarised transport and axon regeneration from the axon initial segment J Cell Sci 2017 130 3663 75 28935671 PMC5702059
- [31]Ueno M Nakamura Y Li J Gu Z Niehaus J Maezawa M Corticospinal circuits from the sensory and motor cortices differentially regulate skilled movements through distinct spinal interneurons Cell Rep 2018 23 1286 29719245 PMC6608728
- [32]Du K Zheng S Zhang Q Li S Gao X Wang J Pten deletion promotes regrowth of corticospinal tract axons 1 year after spinal cord injury J Neurosci 2015 35 9754 63 26134657 PMC6605149
- [33]Gennaro M, Mattiello A, Mazziotti R, Antonelli C, Gherardini L, Guzzetta A, et al. Focal stroke in the developing rat motor cortex induces age- and experience-dependent maladaptive plasticity of corticospinal system. Front Neural Circuits. 2017;11. 10.3389/fncir.2017.00047. PMC5489564 28706475 · DOI
- [34]Haenzi B Gers-Barlag K Akhoundzadeh H Hutson TH Menezes SC Bunge MB Overexpression of the fibroblast growth factor receptor 1 (FGFR1) in a model of spinal cord injury in rats PLoS ONE 2016 11 e0150541 27015635 PMC4807820
- [35]Maeda H Fukuda S Kameda H Murabe N Isoo N Mizukami H Corticospinal axons make direct synaptic connections with spinal motoneurons innervating forearm muscles early during postnatal development in the rat J Physiol 2016 594 189 205 26503304 PMC4704511
- [36]Hodgetts SI, Yoon JH, Fogliani A, Akinpelu EA, Baron-Heeris D, Houwers IGJ, et al. Cortical AAV-CNTF gene therapy combined with intraspinal mesenchymal precursor cell transplantation promotes functional and morphological outcomes after spinal cord injury in adult rats. Neural Plast. 2018. 10.1155/2018/9828725. PMC6139201 30245710 · DOI
- [37]Jin D Liu Y Sun F Wang X Liu X He Z Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3 Nat Commun 2015 6 8074 26598325 PMC4662086
- [38]Liu Y Wang X Li W Zhang Q Li Y Zhang Z A sensitized IGF1 treatment restores corticospinal axon-dependent functions Neuron 2017 95 817 33 28817801 PMC5582621
- [39]Kaludov N Brown KE Walters RW Zabner J Chiorini JA Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity J Virol 2001 75 6884 93 11435568 PMC114416
- [40]Seiler MP Miller AD Zabner J Halbert CL Adeno-associated virus types 5 and 6 use distinct receptors for cell entry Hum Gene Ther 2006 17 10 19 16409121
- [41]Wu Z Miller E Agbandje-McKenna M Samulski RJ α2,3 and α2,6 N-Linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6 J Virol 2006 80 9093 103 16940521 PMC1563919
- [42]Mietzsch M Broecker F Reinhardt A Seeberger PH Heilbronn R Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans J Virol 2014 88 2991 3003 24371066 PMC3958061
- [43]Kaminsky PM Keiser NW Yan Z Lei-Butters DC Engelhardt JF Directing integrin-linked endocytosis of recombinant AAV enhances productive fak-dependent transduction Mol Ther 2012 20 972 83 22233580 PMC3345987
- [44]Zhang R, Xu G, Cao L, Sun Z, He Y, Cui M, et al. Divergent engagements between adeno-associated viruses with their cellular receptor AAVR. Nat Commun. 2019;10. 10.1038/s41467-019-11668-x. PMC6704107 31434885 · DOI
- [45]Bantel-Schaal U Hub B Kartenbeck J Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the golgi compartment J Virol 2002 76 2340 9 11836412 PMC153830
- [46]Keiser NW Yan Z Zhang Y Lei-Butters DCM Engelhardt JF Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells Hum Gene Ther 2011 22 1433 44 21574868 PMC3225038
- [47]Aschauer DF Kreuz S Rumpel S Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain PLoS ONE 2013 8 e76310 24086725 PMC3785459
- [48]Salegio EA Samaranch L Kells AP Mittermeyer G Sebastian WS Zhou S Axonal transport of adeno-associated viral vectors is serotype-dependent Gene Ther 2013 20 348 52 22418061 PMC3381869
- [49]Tervo DGR Hwang B-Y Viswanathan S Gaj T Lavzin M Ritola KD A designer AAV variant permits efficient retrograde access to projection neurons Neuron 2016 92 372 82 27720486 PMC5872824
- [50]Wang Z Maunze B Wang Y Tsoulfas P Blackmore MG Global Connectivity and function of descending spinal input revealed by 3D microscopy and retrograde transduction J Neurosci 2018 38 10566 81 30341180 PMC6284107
- [51]Jayaprakash N, Nowak D, Eastwood E, Krueger N, Wang Z, Blackmore MG. Restoration of direct corticospinal communication across sites of spinal injury. bioRxiv. 2019:546374.
- [52]Kügler S Kilic E Bähr M Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area Gene Ther 2003 10 337 47 12595892
- [53]McLean JR Smith GA Rocha EM Hayes MA Beagan JA Hallett PJ Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection Neurosci Lett 2014 576 73 8 24882721
- [54]Thiel G Greengard P Südhof TC Characterization of tissue-specific transcription by the human synapsin I gene promoter Proc Natl Acad Sci USA 1991 88 3431 5 1849657 PMC51461
- [55]Hilton BJ Anenberg E Harrison TC Boyd JD Murphy TH Tetzlaff W Re-establishment of cortical motor output maps and spontaneous functional recovery via spared dorsolaterally projecting corticospinal neurons after dorsal column spinal cord injury in adult mice J Neurosci 2016 36 4080 92 27053214 PMC6705513
- [56]Hioki H Kameda H Nakamura H Okunomiya T Ohira K Nakamura K Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters Gene Ther 2007 14 872 82 17361216
- [57]Shevtsova Z Malik JMI Michel U Bähr M Kügler S Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo Exp Physiol 2005 90 53 9 15542619
- [58]Andrews MR, Soleman S, Cheah M, Tumbarello DA, Mason MRJ, Moloney E, et al. Axonal localization of integrins in the CNS is neuronal type and age dependent. eNeuro. 2016;3. 10.1523/ENEURO.0029-16.2016. PMC4987411 27570822 · DOI
- [59]Delzor A Dufour N Petit F Guillermier M Houitte D Auregan G Restricted transgene expression in the brain with cell-type specific neuronal promoters Hum Gene Ther Methods 2012 23 242 54 22934828 PMC4015079
- [60]Kordower JH Bloch J Ma SY Chu Y Palfi S Roitberg BZ Lentiviral gene transfer to the nonhuman primate brain Exp Neurol 1999 160 1 16 10630186
- [61]Deglon N Tseng JL Bensadoun J-C Zurn AD Arsenijevic Y Almeida LPD Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson’s disease Hum Gene Ther 2000 11 179 90 10646649
- [62]Alves S Bode J Bemelmans A-P Kalle Cvon Cartier N Tews B Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain Sci Rep 2016 6 1 12 27320056 PMC4913310
- [63]Orefice NS Souchet B Braudeau J Alves S Piguet F Collaud F Real-time monitoring of exosome enveloped-AAV spreading by endomicroscopy approach: a new tool for gene delivery in the brain Mol Ther Methods Clin Dev 2019 14 237 51 31440523 PMC6699252
- [64]Nickells RW Schmitt HM Maes ME Schlamp CL AAV2-mediated transduction of the mouse retina after optic nerve injury Invest Ophthalmol Vis Sci 2017 58 6091 104 29204649 PMC5716181
- [65]McCown TJ Xiao X Li J Breese GR Jude Samulski R Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector Brain Res 1996 713 99 107 8724980
- [66]Klein RL Meyer EM Peel AL Zolotukhin S Meyers C Muzyczka N Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors Exp Neurol 1998 150 183 94 9527887
- [67]Paterna JC Moccetti T Mura A Feldon J Büeler H Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain Gene Ther 2000 7 1304 11 10918501
- [68]Gray SJ Foti SB Schwartz JW Bachaboina L Taylor-Blake B Coleman J Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors Hum Gene Ther 2011 22 1143 53 21476867 PMC3177952
- [69]Prösch S Stein J Staak K Liebenthal C Volk H-D Krüger DH Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro Biol Chem 2009 377 195 202 8722321
- [71]Nuo MT, Yuan JL, Yang WL, Gao XY, He N, Liang H, et al. Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats. Genet Mol Res. 2016;15. 10.4238/gmr.15038560. 27706651 · DOI
- [72]Burger C Gorbatyuk OS Velardo MJ Peden CS Williams P Zolotukhin S Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system Mol Ther 2004 10 302 17 15294177
- [73]Jakobsson J Ericson C Jansson M Björk E Lundberg C Targeted transgene expression in rat brain using lentiviral vectors J Neurosci Res 2003 73 876 85 12949915
- [74]Schober AL, Gagarkin DA, Chen Y, Gao G, Jacobson L, Mongin AA. Recombinant adeno-associated virus serotype 6 (rAAV6) potently and preferentially transduces rat astrocytes in vitro and in vivo. Front Cell Neurosci. 2016;10. 10.3389/fncel.2016.00262. PMC5104754 27891076 · DOI
- [76]Pignataro D, Sucunza D, Vanrell L, Lopez-Franco E, Dopeso-Reyes IG, Vales A, et al. Adeno-Associated viral vectors serotype 8 for cell-specific delivery of therapeutic genes in the central nervous system. Front Neuroanat. 2017;11. 10.3389/fnana.2017.00002. PMC5301009 28239341 · DOI
- [77]Maes ME Colombo G Schulz R Siegert S Targeting microglia with lentivirus and AAV: recent advances and remaining challenges Neurosci Lett 2019 707 134310 31158432 PMC6734419
- [78]Bartlett JS Samulski RJ McCown TJ Selective and rapid uptake of adeno-associated virus type 2 in brain Hum Gene Ther 1998 9 1181 6 9625257
- [79]Cucchiarini M Ren XL Perides G Terwilliger EF Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors Gene Ther 2003 10 657 67 12692594
- [80]Rosario AM, Cruz PE, Ceballos-Diaz C, Strickland MR, Siemienski Z, Pardo M, et al. Microglia-specific targeting by novel capsid-modified AAV6 vectors. Mol Ther Methods Clin Dev. 2016;3. 10.1038/mtm.2016.26. PMC4909093 27308302 · DOI
- [81]Grace PM Strand KA Galer EL Urban DJ Wang X Baratta MV Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation Proc Natl Acad Sci USA 2016 113 E3441 50 27247388 PMC4914184
- [82]Zhang Y Williams PR Jacobi A Wang C Goel A Hirano AA Elevating growth factor responsiveness and axon regeneration by modulating presynaptic inputs Neuron 2019 103 39 51 31122676 PMC7350660
- Authors
- Nieuwenhuis, B., Haenzi, B., Hilton, S., Carnicer-Lombarte, A., Hobo, B., Verhaagen, J., & Fawcett, J. W.
- Affiliations
- Netherlands Institute for Neuroscience (NL)
- University of Cambridge (GB)
- Corresponding author
- Nieuwenhuis, Bart
- ORCID
- Venue
- Gene Therapy
- Published
- 2020-06-23
- Volume
- 28
- Issue
- 1-2
- Pages
- 56-74
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- PMC
- PMC7902269
- OpenAlex
- W3035790625
- Cited by
- 114
- References
- 87
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 11 · 2023: 20 · 2022: 33 · 2021: 13 · 2020: 3
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Gene Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- VU Research Portal (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Figshare (cc-by)
- Funders
- Cancer Research UK
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (013-16-002)
- Medical Research Council (MR/R004463/1, MR/R004544/1, MR/V002694/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- adeno-associated virus vectors, AAV1, corticospinal tract, promoter, transgene expression, phosphoglycerate kinase promoter, synapsin promoter, cytomegalovirus promoter, CAG promoter, sensorimotor cortex, neuron-specific expression, oligodendrocytes, astrocytes, spinal cord injury
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Promoter Regions, Genetic, Pyramidal Tracts, Transduction, Genetic, Transgenes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review